Standardization of marketed formulation Kipen Tablet for analgesic and anti-inflammatory potential
The primary objective of the current investigation was to standardize the formulation Kipen Tablet marketed as patented and proprietary medicine for treatment of various conditions of Pitta, according to the WHO guidelines. The procured tablets of Kipen were Light green in color, with no odor and a bitter taste. Kipen exhibited 8.1% total ash with 2.35% acid insoluble ash and 4.95% water soluble ash. The water soluble and alcohol soluble extractives were 1.36% and 1.3% respectively. The results of preliminary qualitative phytochemical screening revealed that all the classes of phytochemicals were present in Kipen. TLC analysis of Kipen was done using Curcumin as the marker using ethyleacetate: n-hexane (3:7) as the solvent system. Curcumin appeared at Rf value of 0.56 on the TLC plate. The quantitation of the curcumin was done by HPLC method and it was found that Kipen contained 3.75 mg curcumin per 250 mg of Kipen (1.5 %). The anti-inflammatory activity was evaluated using carrageenan induced rat paw edema method and it was seen that Kipen was able to inhibit about 51% edema formation in rat paws. The analgesic action of Kipen was evaluated using tail flick method and the response time pain stimulus (thermal) was observed. The highest reaction time for Kipen was 6.26 ± 0.06.15 ± 0.242 sec at 30 min post administration while it was 3.46 ± 0.095 sec and 6.22 ± 0.171 sec for vehicle treated and Ibuprofen treated group respectively at the same time duration.
2. Wani MS. Herbal medicine and its standardization. Pharmaceutical Reviews, 2007; 5(6).
3. Vaidya ADB and Devasagayam TPA. Current status of herbal drugs in India: An overview. J Clin Biochem, 2007; 41(1):1–11.
4. Sharma V, Kaushik R, Rai P. Comparative Study of Herbal Formulation and Marketed Formulation of TriphalaChurna. Int J Pharm Edu Res, 2020; 2(1): 21-29.
5. Pal RS, Pal Y, Wal P, Wal A. In house & Marketed Preparation of HingwashtakChurna, A Polyherbal Formulation: Comparative Standardization and Measures. Open Med J, 2018; 5: 76-83.
6. Matotoka MM, Masoko P. Phytochemical screening and pharmacological evaluation of herbal concoctions sold at Ga Maja Limpopo Province. South Afr J Bot, 2018; 117: 1-10.
7. Wadkar KA, Kondawar MS, Lokapure SG. Standardization of marketed cystone tablet: A herbal formulation. J Pharmacogn Phytochem, 2017; 6(2): 10-16
8. Khan TA, Mallya R, Gohel A. Standardization of marketed Ayurvedic formulation, Balaguloochyadikashayam- physicochemical, microbial evaluation and ephedrine content. J Appl Pharm Sci, 2016; 6(12): 184-189.
9. Randive DS, Bhinge SD, Wadkar GH, Sayyad SF, Bhutkar MA. Comparative standardization of marketed formulations of fermented biomedicine – Arjunaristha. Indonesian J Pharm, 2016; 27(4): 220-225.
10. Shaikh RH, Jamadar MJ. Standardization of marketed herbal product Kawach Beej churna. J Medical Pharm Allied Sci, 2016; 27-48
11. Patil AB, Pande VV, Patil PB. Comparative evaluation and standardization of marketed herbal antiobesity formulation. Der Pharmacia Sinica, 2015; 6(4): 1-8.
12. Chumbhale DS, Chaudhari SR, Upasani CD. Standardization of marketed kumariasava- a polyherbal ayurvedic formulation. Int J Pharm Chem Biol Sci, 2014; 4(3): 681-685.
13. Deshpande SG, Kasture VS, Gosavi SA, Bhalke RD, Ajage RK, Inamke SR, Kolpe JB, Jadhav GP. Pharmacognostic Evaluation of Polyherbal Marketed Formulation. Int J Pharmacogn Phytochemical Res, 2014; 6(3): 588-592
14. Bahuguna Y, Zaidi S, Kumar N, Rawat K. Standardization of Polyherbal Marketed Formulation Triphala Churna. Res and Rev: J Pharmacogn Phytochem, 2014; 2(3): 28-35
15. Shivatare RS, Pande AS, Bhusnar HU, Kadam PV, Yadav KN, Patil MJ. Standardization of Narasimha Churna: A Poly-Herbal Formulation. Asian J Biomedical Pharm Sci, 2013; 3(23): 23-27.
16. Charde MS, Chakolkar MD, Welankiwar AS, Keshwar U, Shrikhande BK. standardization of marketed Herbal formulation of muscle and joint Hrx Pain Relieving Oil. Int J Advances Pharmaceut, 2013; 2(5): 58-62.
17. Karthi J, Kalvimoorthi V, Thamizh Mozhi M. Standardisation of sudharshana churna polyherbal formulation. Int J Pharm Chemical Biol Sci, 2012; 2(3): 343-347.
19. Anonymous. Quality Control Methods for Medicinal Plant Materials. World Health Organisation. Geneva, (1998) 25-28
20. Meena AK et al. Standardisation of Ayurvedic polyherbal formulation, Pancasama Churna. International Journal of Pharmacognosy and Phytochemical Research, 2010; 1: 11-14.
21. Mukerjee PK. Quality control of herbal drugs, Business horizons Pharmaceutical publisher, New Delhi, 2002.
22. Mehta S, Singh RP, Saklani P. Phytochemical screening and TLC profiling of various extracts of Reinwardtia indica. Int J Pharmacogn Phytochem Res, 2017; 9(4): 523-527.
23. Wichitnithad W, Jongaroonngamsang N, Pummangura S, Rojsitthisak P. A Simple Isocratic HPLC Method for the Simultaneous Determination of Curcuminoids in Commercial Turmeric Extracts. Phytochem Anal, 2009; 20(4): 314-319. DOI 10.1002/pca.1129.
24. Kemisetti D, Manda S. Synthesis and comparison of peg-ibuprofen and peg-ketoprofen prodrugs by in vitro and in vivo evaluation. J Drug Del Ther, 2018; 8(4): 145-154.
25. Fan S-H, Ali NA, Basri DF. Evaluation of Analgesic Activity of the Methanol Extract from the Galls of Quercus infectoria (Olivier) in Rats. Evidence-Based Complementary and Alternative Medicine, 2014; http://dx.doi.org/10.1155/2014/976764
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).